Get started
Author

Suranur Ayvaz

Observed name: Şuranur Ayvaz
ORCID: 0000-0002-3312-657X
Observed ORCID: 0000-0002-3312-657X
OpenAlex ID: A5116503570
All-trans retinoic acid enhances anti-proliferative effect of dual PI3K and mTOR inhibitor NVP-BEZ235 in triple negative breast cancer
2025 · Suranur Ayvaz, Zeynep Busra Bolat · Naunyn-Schmiedeberg s Archives of Pharmacology · 6
BH3 mimetic and dual PI3K/mTOR inhibitor attenuates gemcitabine resistance in triple-negative breast cancer
2025 · Gizem Selimoglu, Suranur Ayvaz, et al. · Medical Oncology · 3
Potential uses of Ginkgo biloba in the treatment of Alzheimer's disease
2026 · Yaren Oktay, Şuranur Ayvaz, et al. · Journal of Apitherapy and Nature
PDF
Combination of Pan-EGFR inhibitor and all-trans retinoic acid suppresses the migration ability of triple negative breast cancer MDA-MB-231 cell line
2026 · Suranur Ayvaz, Sevval Merve Ismailoglu, et al. · Gene Reports
Suppression of glioblastoma progression by novel Phthalocyanine derivatives: In vitro characterization and molecular docking analysis
2026 · Şuranur Ayvaz, Nevzat Batan, et al. · Journal of Inorganic Biochemistry
Works count: 5
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type